|
1
|
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.
|
Blood
|
2007
|
2.21
|
|
2
|
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
|
PLoS Pathog
|
2009
|
1.81
|
|
3
|
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?
|
J Transl Med
|
2011
|
1.36
|
|
4
|
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
|
J Virol
|
2004
|
1.32
|
|
5
|
Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus.
|
J Infect Dis
|
2005
|
1.24
|
|
6
|
Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.
|
J Clin Microbiol
|
2009
|
1.23
|
|
7
|
CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.
|
J Virol
|
2011
|
1.19
|
|
8
|
HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.
|
Blood
|
2007
|
1.19
|
|
9
|
Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
|
J Virol
|
2006
|
1.04
|
|
10
|
Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.
|
J Virol
|
2009
|
1.01
|
|
11
|
Activation of T lymphocytes in atherosclerotic plaques.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.00
|
|
12
|
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
|
J Virol
|
2005
|
0.99
|
|
13
|
Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue.
|
AIDS
|
2002
|
0.92
|
|
14
|
Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
|
J Virol
|
2004
|
0.87
|
|
15
|
Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.
|
AIDS Res Hum Retroviruses
|
2003
|
0.86
|
|
16
|
Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.
|
J Virol
|
2007
|
0.86
|
|
17
|
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.
|
Retrovirology
|
2009
|
0.85
|
|
18
|
Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1.
|
Virology
|
2004
|
0.85
|
|
19
|
Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.
|
AIDS Res Hum Retroviruses
|
2008
|
0.83
|
|
20
|
HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo.
|
PLoS One
|
2012
|
0.82
|